Lyka Labs
Lyka Labs Share Price Chart
Lyka Labs last traded at ₹72.20 (2026-10-13). Over the past month the stock moved -14.0%, three months the stock moved +20.1%, year the stock moved -27.9%. Its closing range over 52 weeks is ₹46.52 – ₹94.86, with the latest close 23.9% below the high.
Closing prices up to 2026-10-13.
About Lyka Labs
Incorporated in 1976, Lyka Labs Ltd is in the development, manufacture and marketing of quality finished dosages[1]
Business Overview:[1] LLL is a WHO-GMP certified and ISO 9001- certified manufacturer of Pharmaceutical Formulations & Active Pharmaceutical Ingredients across various therapeutic segments, including Lyophilized injections, topical formulations of cream, ointment, foams, gels & lotions.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Lyka Labs reported sales of ₹42.31 crore (+28.1%) and net profit of ₹2.05 crore (+107.1%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 42.31 | 4.55 | 10.75 | 2.05 | 0.57 |
| Mar 2026 | 28.03 | -6.45 | -23.01 | -8.07 | -2.13 |
| Dec 2025 | 30.73 | 1.65 | 5.37 | -0.15 | 0.00 |
| Sep 2025 | 36.66 | -2.54 | -6.93 | -3.22 | -0.94 |
| Jun 2025 | 33.03 | 3.68 | 11.14 | 0.99 | 0.26 |
| Mar 2025 | 33.43 | 4.08 | 12.20 | 2.03 | 0.50 |
| Dec 2024 | 33.80 | 5.19 | 15.36 | 2.70 | 0.76 |
| Sep 2024 | 41.16 | 4.95 | 12.03 | 1.91 | 0.59 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +47.1% | +3.8% | +20.4% | +9.7% | -10.9% | -9.1% | -16.2% | +28.1% |
| Operating profit growth | +18.7% | -24.5% | +102.0% | -0.8% | -151.3% | -68.2% | -258.1% | +23.6% |
| Net profit growth | – | +51.7% | – | -23.3% | -268.6% | -105.6% | -497.5% | +107.1% |
| EPS growth | – | +40.7% | – | -35.0% | -259.3% | -100.0% | -526.0% | +119.2% |
| OPM % | 12.0% | 15.4% | 12.2% | 11.1% | -6.9% | 5.4% | -23.0% | 10.8% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Lyka Labs reported sales of ₹128.00 crore (-7.2%) and net profit of ₹-10.00 crore (-225.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 128.00 | -4.00 | -3.00 | -10.00 | -2.81 |
| Mar 2025 | 138.00 | 18.00 | 13.00 | 8.00 | 2.24 |
| Mar 2024 | 111.00 | 16.00 | 14.00 | -3.00 | -0.75 |
| Mar 2023 | 93.00 | 17.00 | 18.00 | -13.00 | -4.30 |
| Mar 2022 | 194.00 | 101.00 | 52.00 | 38.00 | 13.59 |
| Mar 2021 | 86.00 | 20.00 | 23.00 | -10.00 | -4.03 |
| Mar 2020 | 61.00 | -4.00 | -6.00 | -63.00 | -21.10 |
| Mar 2019 | 71.00 | -2.00 | -3.00 | -6.00 | -1.97 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +18.3% | -14.1% | +41.0% | +125.6% | -52.1% | +19.4% | +24.3% | -7.2% |
| Operating profit growth | – | – | – | +405.0% | -83.2% | -5.9% | +12.5% | -122.2% |
| Net profit growth | – | – | – | – | -134.2% | – | – | -225.0% |
| EPS growth | – | – | – | – | -131.6% | – | – | -225.4% |
| OPM % | -3.0% | -6.0% | 23.0% | 52.0% | 18.0% | 14.0% | 13.0% | -3.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Lyka Labs.
Get Free AI Stock Analysis FREE →Latest News
-
Lyka Labs Consolidated June 2026 Net Sales at Rs 42.31 crore, up 28.11% Y-o-Y - Moneycontrol.com
-
Lyka Labs consolidated net profit rises 122.58% in the June 2026 quarter - Business Standard
Frequently Asked Questions
What is the share price of Lyka Labs today?
Lyka Labs shares were last quoted at ₹72.20 (-0.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Lyka Labs?
Lyka Labs has a price-to-earnings (P/E) ratio of -9.69 and a price-to-book (P/B) ratio of 3.18. The industry P/E is 52.82.
What is the 52-week high and low of Lyka Labs?
The 52-week high of Lyka Labs is ₹104.80 and the 52-week low is ₹44.49.
What is the market cap of Lyka Labs?
The market capitalisation of Lyka Labs is about ₹300.47 crore.
How did Lyka Labs perform in its latest quarterly results?
In the latest quarter (Jun 2026), Lyka Labs reported sales of ₹42.31 crore (+28.1%) and net profit of ₹2.05 crore (+107.1%), compared with the same quarter last year.
Is Lyka Labs a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Lyka Labs has a 3-year ROE of -2.00%, 3-year profit growth of -32.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Lyka Labs?
Promoters hold about 58.45% of Lyka Labs.
Which sector does Lyka Labs belong to?
Lyka Labs belongs to the Pharmaceuticals & Drugs sector.